Table 4. Serum Lipids and Apolipoproteins Between the Heterogeneous and Homogeneous Type in the ATBI Group.
| Variables | Heterogeneous type (n = 21 ) | Homogenous type (n = 27) |
|---|---|---|
| Serum lipids | ||
| TC, mg/dL | 170.0 ± 23.2a | 188.4 ± 39.3 |
| LDL-C, mg/dL | 98.0 ± 23.2 | 113.6 ± 31.6 |
| MDA-LDL, U/L | 87.0 ± 33.3a | 116.9 ± 50.3 |
| HDL-C, mg/dL | 53.6 ± 13.7 | 54.3 ± 10.9 |
| TG, mg/dL | 123.2 ± 43.4 | 153.7 ± 92.0 |
| RLP-C, mg/dL | 7.0 ± 8.9 | 5.8 ± 4.0 |
| Lp (a), mg/dL | 28.3 ± 28.5a | 10.6 ± 9.4 |
| Apolipoproteins | ||
| ApoA1, mg/dL | 121.0 ± 19.6a | 133.8 ± 19.2 |
| ApoA2, mg/dL | 26.0 ± 4.2a | 29.3 ± 5.4 |
| ApoB, mg/dL | 74.7 ± 15.9 | 82.4 ± 18.4 |
| ApoC2, mg/dL | 4.2 ± 1.8 | 4.7 ± 1.5 |
| ApoC3, mg/dL | 8.6 ± 3.4 | 10.4 ± 4.4 |
| ApoE, mg/dL | 2.8 ± 0.9 | 3.2 ± 1.3 |
| HbA1c, % | 6.6 ± 1.3 | 6.5 ± 1.6 |
aP < 0.05, vs. homogenous type. ATBI: atherothrombotic infraction; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; MDA-LDL: malondialdehyde-modified low-density lipoprotein; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; RLP-C: remnant lipoprotein cholesterol; Lp(a): lipoprotein(a); ApoA1: apolipoprotein A1; ApoA2: apolipoprotein A2; ApoB: apolipoprotein B; ApoC1: apolipoprotein C1; ApoC2: apolipoprotein C2; ApoE: apolipoprotein E; HbA1c: hemoglobin A1c.